(redirected from biomarker)
Also found in: Dictionary, Medical, Legal, Financial, Acronyms, Encyclopedia, Wikipedia.
  • noun

Synonyms for marker

some conspicuous object used to distinguish or mark something

a writing implement for making a mark

References in periodicals archive ?
The National Heart, Lung, and Blood Institute (NHLBI) invites applications for research grants to identify novel biomarkers of chronic obstructive pulmonary disease (COPD).
com/research/c576bc/the_state_of_bioma) has announced the addition of the "The State of Biomarkers in Clinical Development" report to their offering.
A biomarker should allow better measurements of exposure or earlier identification of health effects.
Much of the Arctic conference focused on biomarkers under development to measure exposures to pollutants, their effects, and variations in people's susceptibility to such effects.
20 (Regulatory perspective for biomarker qualification from US-FDA (Federico Goodsaid)
This report contains over 700 links to online copies of actual biomarker deals and contract documents as submitted to the Securities Exchange Commission by companies and their partners.
Biochemistry of Cancer Cells Carcinogen Metabolism Causes of Cancer Growth Environmental Factors, DNA, RNA Cellular Oncogenes Tumor Suppressor Genes History of Cancer Cancer Types Biomarker Examples New Developments Total Market Size and Forecast Cancer Biomarker Market by Geographical Region Competitor Summary CHAPTER FIVE: BIOMARKERS IN CARDIOVASCULAR DISEASE AND BLOOD DISORDERS Overview The Cardiovascular System Heart Circulatory System Cardiac Cycle Coronary Circulation Cardiac Myocytes Molecular Contraction Cardiovascular And Blood Diseases Ischemic Heart Disease
As the field of biomarker research matures, patient stratification will become routine.
The high growth of biomarker market is boosted by the demand from the baby boomer generation in the U.
There is a real desire within our industry for a better understanding of how biomarkers are being incorporated into clinical trials.
The report suggests investment decisions in biomarker based drug research by providing information on valid biomarkers, pipelines, case studies, competitive landscape, geographical dominance, mergers and acquisitions and market potential.
com/research/9e56e9/european_biomarker) has announced the addition of Frost & Sullivan's new report "European Biomarker Analysis Market" to their offering.
Biomarker markets are estimated from 2008 to 2018 according to share of markets for various technologies and applications: proteomics, metabolomics, molecular diagnostics, drug discovery, clinical trials, and bioinformatics.